AAPL338.11+1.11 (+0.33%) ▲|ABBV263.19-0.82 (-0.31%) ▼|ABT102.26+0.03 (+0.03%) ▲|ACN185.30-4.98 (-2.62%) ▼|ADBE249.24-3.43 (-1.36%) ▼|AMAT428.38+10.98 (+2.63%) ▲|AMD547.76+2.67 (+0.49%) ▲|AMGN382.29+2.51 (+0.66%) ▲|AMT174.00-1.62 (-0.92%) ▼|AMZN252.53+1.34 (+0.53%) ▲|AVGO360.56+13.26 (+3.82%) ▲|AXP309.73-1.75 (-0.56%) ▼|BA197.61+0.55 (+0.28%) ▲|BAC57.79-0.38 (-0.65%) ▼|BKNG169.71-0.81 (-0.48%) ▼|BLK1,047.92-5.84 (-0.55%) ▼|BMY62.43-0.41 (-0.64%) ▼|BNY152.74-0.30 (-0.19%) ▼|BRK-B507.43-1.68 (-0.33%) ▼|C132.18-0.52 (-0.39%) ▼|CAT808.88+10.43 (+1.31%) ▲|CL87.26-0.47 (-0.54%) ▼|CMCSA22.58-0.34 (-1.46%) ▼|COF201.89-0.10 (-0.05%) ▼|COP133.10-0.11 (-0.08%) ▼|COST894.23+0.30 (+0.03%) ▲|CRM240.73-2.31 (-0.95%) ▼|CSCO110.43+0.19 (+0.18%) ▲|CVS88.98-1.29 (-1.43%) ▼|CVX211.72+0.13 (+0.06%) ▲|DE685.41-0.20 (-0.03%) ▼|DHR212.02-0.49 (-0.23%) ▼|DIS103.56-1.78 (-1.69%) ▼|DUK117.40-1.16 (-0.98%) ▼|EMR148.09+0.70 (+0.47%) ▲|FDX304.81-1.09 (-0.35%) ▼|GD355.30-0.63 (-0.18%) ▼|GE311.50-2.11 (-0.67%) ▼|GEV946.50+21.15 (+2.29%) ▲|GILD151.48+0.59 (+0.39%) ▲|GM84.95-1.65 (-1.91%) ▼|GOOG351.70+8.02 (+2.33%) ▲|GOOGL355.65+8.32 (+2.40%) ▲|GS946.13-4.99 (-0.52%) ▼|HD298.82-3.70 (-1.22%) ▼|HON205.94-0.55 (-0.27%) ▼|IBM233.44-4.37 (-1.84%) ▼|INTC109.72+0.92 (+0.85%) ▲|INTU306.83-6.31 (-2.01%) ▼|ISRG393.49+9.95 (+2.59%) ▲|JNJ268.02-2.20 (-0.81%) ▼|JPM346.15-3.10 (-0.89%) ▼|KO87.87-0.20 (-0.22%) ▼|LIN455.21-3.28 (-0.71%) ▼|LLY1,150.60-1.72 (-0.15%) ▼|LMT535.00-2.96 (-0.55%) ▼|LOW192.76-1.37 (-0.70%) ▼|LRCX279.23+9.92 (+3.68%) ▲|MA564.08-1.68 (-0.30%) ▼|MCD248.09-0.39 (-0.16%) ▼|MDLZ60.80-1.25 (-2.01%) ▼|MDT92.40-0.41 (-0.44%) ▼|META672.81-9.51 (-1.39%) ▼|MMM164.09-0.64 (-0.39%) ▼|MO69.27-0.43 (-0.62%) ▼|MRK146.53-0.60 (-0.41%) ▼|MS202.12-1.36 (-0.67%) ▼|MSFT493.74-4.01 (-0.81%) ▼|MU990.46+12.96 (+1.33%) ▲|NEE80.64-0.62 (-0.76%) ▼|NFLX71.37-3.94 (-5.23%) ▼|NKE36.22-0.17 (-0.46%) ▼|NOW137.07-1.43 (-1.03%) ▼|NVDA219.73+0.39 (+0.18%) ▲|ORCL146.68-3.90 (-2.59%) ▼|PEP130.19-3.47 (-2.60%) ▼|PFE27.45-0.19 (-0.69%) ▼|PG146.33-1.18 (-0.80%) ▼|PLTR172.84-3.40 (-1.93%) ▼|PM188.19-2.33 (-1.22%) ▼|QCOM187.44-1.27 (-0.67%) ▼|RTX192.73-0.81 (-0.42%) ▼|SBUX95.45-1.22 (-1.26%) ▼|SCHW104.80+0.17 (+0.16%) ▲|SO85.91-0.85 (-0.98%) ▼|SPG203.48-0.99 (-0.48%) ▼|T25.35-0.04 (-0.16%) ▼|TMO657.36-1.34 (-0.20%) ▼|TMUS165.60-0.85 (-0.51%) ▼|TSLA369.71+3.51 (+0.96%) ▲|TXN261.94+3.80 (+1.47%) ▲|UBER70.36-0.51 (-0.72%) ▼|UNH374.12-1.09 (-0.29%) ▼|UNP279.19-3.30 (-1.17%) ▼|UPS99.33-0.84 (-0.84%) ▼|USB59.97-0.29 (-0.47%) ▼|V368.04-1.89 (-0.51%) ▼|VZ47.71-0.63 (-1.29%) ▼|WFC86.27-0.62 (-0.71%) ▼|WMT107.63+0.84 (+0.79%) ▲|XOM162.59-0.68 (-0.42%) ▼|AAPL338.11+1.11 (+0.33%) ▲|ABBV263.19-0.82 (-0.31%) ▼|ABT102.26+0.03 (+0.03%) ▲|ACN185.30-4.98 (-2.62%) ▼|ADBE249.24-3.43 (-1.36%) ▼|AMAT428.38+10.98 (+2.63%) ▲|AMD547.76+2.67 (+0.49%) ▲|AMGN382.29+2.51 (+0.66%) ▲|AMT174.00-1.62 (-0.92%) ▼|AMZN252.53+1.34 (+0.53%) ▲|AVGO360.56+13.26 (+3.82%) ▲|AXP309.73-1.75 (-0.56%) ▼|BA197.61+0.55 (+0.28%) ▲|BAC57.79-0.38 (-0.65%) ▼|BKNG169.71-0.81 (-0.48%) ▼|BLK1,047.92-5.84 (-0.55%) ▼|BMY62.43-0.41 (-0.64%) ▼|BNY152.74-0.30 (-0.19%) ▼|BRK-B507.43-1.68 (-0.33%) ▼|C132.18-0.52 (-0.39%) ▼|CAT808.88+10.43 (+1.31%) ▲|CL87.26-0.47 (-0.54%) ▼|CMCSA22.58-0.34 (-1.46%) ▼|COF201.89-0.10 (-0.05%) ▼|COP133.10-0.11 (-0.08%) ▼|COST894.23+0.30 (+0.03%) ▲|CRM240.73-2.31 (-0.95%) ▼|CSCO110.43+0.19 (+0.18%) ▲|CVS88.98-1.29 (-1.43%) ▼|CVX211.72+0.13 (+0.06%) ▲|DE685.41-0.20 (-0.03%) ▼|DHR212.02-0.49 (-0.23%) ▼|DIS103.56-1.78 (-1.69%) ▼|DUK117.40-1.16 (-0.98%) ▼|EMR148.09+0.70 (+0.47%) ▲|FDX304.81-1.09 (-0.35%) ▼|GD355.30-0.63 (-0.18%) ▼|GE311.50-2.11 (-0.67%) ▼|GEV946.50+21.15 (+2.29%) ▲|GILD151.48+0.59 (+0.39%) ▲|GM84.95-1.65 (-1.91%) ▼|GOOG351.70+8.02 (+2.33%) ▲|GOOGL355.65+8.32 (+2.40%) ▲|GS946.13-4.99 (-0.52%) ▼|HD298.82-3.70 (-1.22%) ▼|HON205.94-0.55 (-0.27%) ▼|IBM233.44-4.37 (-1.84%) ▼|INTC109.72+0.92 (+0.85%) ▲|INTU306.83-6.31 (-2.01%) ▼|ISRG393.49+9.95 (+2.59%) ▲|JNJ268.02-2.20 (-0.81%) ▼|JPM346.15-3.10 (-0.89%) ▼|KO87.87-0.20 (-0.22%) ▼|LIN455.21-3.28 (-0.71%) ▼|LLY1,150.60-1.72 (-0.15%) ▼|LMT535.00-2.96 (-0.55%) ▼|LOW192.76-1.37 (-0.70%) ▼|LRCX279.23+9.92 (+3.68%) ▲|MA564.08-1.68 (-0.30%) ▼|MCD248.09-0.39 (-0.16%) ▼|MDLZ60.80-1.25 (-2.01%) ▼|MDT92.40-0.41 (-0.44%) ▼|META672.81-9.51 (-1.39%) ▼|MMM164.09-0.64 (-0.39%) ▼|MO69.27-0.43 (-0.62%) ▼|MRK146.53-0.60 (-0.41%) ▼|MS202.12-1.36 (-0.67%) ▼|MSFT493.74-4.01 (-0.81%) ▼|MU990.46+12.96 (+1.33%) ▲|NEE80.64-0.62 (-0.76%) ▼|NFLX71.37-3.94 (-5.23%) ▼|NKE36.22-0.17 (-0.46%) ▼|NOW137.07-1.43 (-1.03%) ▼|NVDA219.73+0.39 (+0.18%) ▲|ORCL146.68-3.90 (-2.59%) ▼|PEP130.19-3.47 (-2.60%) ▼|PFE27.45-0.19 (-0.69%) ▼|PG146.33-1.18 (-0.80%) ▼|PLTR172.84-3.40 (-1.93%) ▼|PM188.19-2.33 (-1.22%) ▼|QCOM187.44-1.27 (-0.67%) ▼|RTX192.73-0.81 (-0.42%) ▼|SBUX95.45-1.22 (-1.26%) ▼|SCHW104.80+0.17 (+0.16%) ▲|SO85.91-0.85 (-0.98%) ▼|SPG203.48-0.99 (-0.48%) ▼|T25.35-0.04 (-0.16%) ▼|TMO657.36-1.34 (-0.20%) ▼|TMUS165.60-0.85 (-0.51%) ▼|TSLA369.71+3.51 (+0.96%) ▲|TXN261.94+3.80 (+1.47%) ▲|UBER70.36-0.51 (-0.72%) ▼|UNH374.12-1.09 (-0.29%) ▼|UNP279.19-3.30 (-1.17%) ▼|UPS99.33-0.84 (-0.84%) ▼|USB59.97-0.29 (-0.47%) ▼|V368.04-1.89 (-0.51%) ▼|VZ47.71-0.63 (-1.29%) ▼|WFC86.27-0.62 (-0.71%) ▼|WMT107.63+0.84 (+0.79%) ▲|XOM162.59-0.68 (-0.42%) ▼|
23.5 C
New York
Friday, September 18, 2026

Tag: programs

newssourceFORcompanyinformationcontent1releasesmarket

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Cochlear celebrates 30 Years in China and the launch of the world’s first and only smart hearing implant system

The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable firmware.1+This year marks the 30-year anniversary since...

OMS Energy Technologies Inc. Issues Post-IPO Operational Update Featuring Customer Growth, Expansion Initiatives and R&D and Safety Achievements

SINGAPORE, June 19, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (Nasdaq: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today provided a business update outlining its recent accomplishments as the Company prepares for its inaugural earnings call following its successful Nasdaq listing in May 2025.

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting being held in New Orleans, Louisiana (U.S.) from June 21 – 24.

FinVolution Group Announces Proposed Offering of US$130 Million Convertible Senior Notes

SHANGHAI, June 19, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution" or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines,...

Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline |...

The delta-like ligand 3 targeted therapies market is witnessing significant growth, driven by the rising incidence of small cell lung cancer (SCLC) and neuroendocrine...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

Flagship Communities Real Estate Investment Trust Wins the Kentucky Manufactured Housing Institute’s Highest Award for the Fourth Consecutive Year

Not for distribution to U.S. newswire services or dissemination in the United States.

PECO Pallet Wins CITT Award for Environmental Sustainability

CITT awards PECO its inaugural SME Sustainability Award for environmental leadership. ITASCA, Ill., June 19, 2025 /PRNewswire/ -- PECO Pallet announced today that it...

Biological Safety Cabinets Market to Reach USD 448.4 Million by 2032, Driven by Rising Biosafety Standards and Research Demand

PUNE, India, June 19, 2025 /PRNewswire/ -- According to a recent market analysis published by Credence Research Inc., the global Biological Safety Cabinets (BSCs) market...

BCAA Says Summer Travel Trends Mean Savings on Travel Insurance

- BCAA helps vacationers with tips to choose the right protection and save money BURNABY, BC, June 19, 2025 /CNW/ - BCAA says that the...

Inmispace Announces Plans for Corporate Workshop on Breath, Leadership and Resilience in Singapore

Inmispace, a global wellness company, will host a corporate workshop in Singapore focused on leadership, burnout prevention, and resilience. Led by founder

Anosh Ahmed Drives Major Community Impact Across Chicago Through Healthcare, Education, and Economic Relief Programs

Chicago-based entrepreneur and philanthropist delivers ongoing support to underserved neighborhoods through hands-on initiatives and partnerships

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPrograms

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers